UNCY7:05 AMUnicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonateunicycive.com
UNCY7:05 AMUnicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conferenceunicycive.com
UNCY7:19 AMUnicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updateunicycive.com